Marijuana Moment
A Missouri Senate committee on Wednesday stripped a proposal from a House-passed budget bill that would have funneled $10 million in state opioid settlement money to research psilocybin.
An earlier version of the Republican-led proposal would have instead put the money toward the study of ibogaine as a treatment for opioid use disorder, but a House floor amendment earlier this month switched the focus to psilocybin. After the latest changes in the Senate Appropriations Committee, the budget would allocate no money to psychedelics research of any kind.
Separate Missouri legislation that would legalize the use of medical psilocybin by military veterans and fund future studies exploring the therapeutic potential of the psychedelic, however, is still advancing through the House and Senate.
Read full report
